Wells Fargo Maintains Equal-Weight on Cellectis, Lowers Price Target to $3

Benzinga · 2d ago
Wells Fargo analyst Yanan Zhu maintains Cellectis (NASDAQ:CLLS) with a Equal-Weight and lowers the price target from $4 to $3.